tigecycline
Selected indexed studies
- Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review. (Eur J Clin Microbiol Infect Dis, 2022) [PMID:33403565]
- Tigecycline. (Drugs, 2005) [PMID:16392879]
- Tigecycline-induced coagulopathy: a literature review. (Int J Clin Pharm, 2019) [PMID:31713108]
_Worker-drafted node — pending editorial review._
Connections
tigecycline is a side effect of
Sources
- Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review. (2022) pubmed
- Tigecycline. (2005) pubmed
- Tigecycline-induced coagulopathy: a literature review. (2019) pubmed
- Effectiveness and Safety of High Dose Tigecycline for the Treatment of Severe Infections: A Systematic Review and Meta-Analysis. (2020) pubmed
- The tigecycline resistance mechanisms in Gram-negative bacilli. (2024) pubmed
- Tigecycline: an update. (2013) pubmed
- Molecular mechanisms of tigecycline-resistance among Enterobacterales. (2024) pubmed
- Resistance mechanisms of tigecycline in Acinetobacter baumannii. (2023) pubmed
- Tigecycline: a critical update. (2008) pubmed
- Population Pharmacokinetics of Tigecycline: A Systematic Review. (2022) pubmed